Regent Group, Bernardsville, NJ—through its wholly owned subsidiary Millennium Biotechnologies—has introduced Resurgex™, a proprietary nutra­ceutical drink product. The product incorporates SOD/Gliadin, a patented vegetarian form of the SOD master cellular defense enzyme, developed for oral use. Resurgex is designed to provide support for immuno-compromised individuals undergoing medical treatment for diseases that cause nutrient depletion, tissue wasting (lean muscle loss), oxidative stress (free radical damage) and mitochondrial failure (low energy). The drink was initially launched in New Jersey and Connecticut, where it qualifies for Medicaid reimbursement.